|
|
![](/peth04/20041029014823im_/http://www.cdc.gov/reproductivehealth/images/spacer443x4.gif)
Assisted
Reproductive
Technology Reports
- 2001
Assisted Reproductive Technology
Success Rates
National Summary and Fertility Clinic Reports
View PDF 2,236KB
The 2001 report of pregnancy
success rates is the seventh report to be issued under the
Fertility Clinic Success Rate and Certification Act. The report
includes a national overview that uses information from 384 U.S.
fertility clinics to provide an in-depth picture of the type,
number, and outcome of ART cycles performed in U.S. clinics. The
report also includes
individual clinic tables that provide ART success rates and other
information from each clinic that submitted and verified its 2001
data and appendixes containing the results of data validation visits, technical
notes, a glossary of terms, and contact information for reporting
and nonreporting clinics in the United States.
-
Previous ART Reports
-
2000 | 1999
| 19981995 (PDF format only)
Assisted Reproductive Technology Surveillance United States, 2001
|
View PDF 568KB
With the advent of assisted
reproductive technology (ART) more than 20 years ago, American
couples increasingly have turned to such treatments to overcome
fertility problems. Nationwide, 107,587 procedures were performed
in 2001 by ART fertility treatments in which the egg and sperm
are handled in the laboratory resulting in 29,344 live births and
40,687 infants. This report expands information on geography and
determinants of both ART success and multiple birth risks beyond
that which appears in the 2001 Assisted Reproductive Technology
Success Rates: National Summary and Fertility Clinic Report.
Source: MMWR, April 30,
2004/53(SS01);120.
Previous ART Surveillance Summary
2000
Use
of Assisted Reproductive Technology United States, 1996 and 1998
Since 1983, when the first infant was conceived
from in vitro fertilization (IVF) in the United States, the use of
IVF and related procedures (assisted reproductive technology [ART]) has increased
substantially.
Contribution
of Assisted Reproductive Technology and Ovulation-Inducing Drugs to
Triplet and Higher-Order Multiple Births United States,
19801997
Pregnancies associated with assisted reproductive
technology (ART) and drugs that induce ovulation are more likely to
result in multiple births than spontaneously conceived pregnancies
in the United States. Triplet and higher-order multiple births are
at greater risk than singleton births to be preterm, low or very low
birth weight, which may result in higher infant morbidity and
mortality. This report estimates the connection between these birth
outcomes and ART and ovulation-inducing drugs in 1996 and 1997. It
also summarizes the trends that indicate ART and the use of
ovulation-inducing drugs have increased the ratio of triplet and
higher-order multiple births during the 1980s and most of the 1990s.
Source: MMWR, June 23, 2000/ 49(24);535-8.
Live-Birth Rates and Multiple-Birth Risk Using In
Vitro Fertilization*
To maximize birth rates, physicians who perform in
vitro fertilization (IVF) often transfer multiple embryos, but this
increases the multiple-birth risk. Live-birth and multiple-birth rates
may vary by patient age and embryo quality. One marker for embryo
quality is cryopreservation of extra embryos (if embryos are set aside
for cryopreservation, higher quality embryos may have been available
for transfer). The study found that, the risk of multiple births from
IVF varies by maternal age and number of embryos transferred. Embryo
quality was not related to multiple birth risk but was associated with
increased live-birth rates when fewer embryos were transferred.
Source: JAMA. 1999;282:18321838.
Implementation
of
the Fertility Clinic Success Rate and Certification Act of 1992: A Model
Program for the Certification of Embryo Laboratories
A Model Program for the Certification of Embryo Laboratories The Fertility
Clinic Success Rate and Certification Act of 1992 (Pub. L. 102-493, 42
U.S.C. 263a-1 et seq.) required the Secretary, Department of Health and
Human Services, through the CDC, to develop a model program for the
certification of embryo laboratories, to be carried out voluntarily by
interested states. This notice sets forth the model certification program
requirements, including definitions, administrative requirements, and
embryo laboratory standards. The model program incorporates comments
received by CDC on the proposed model certification program that was
published in the Federal Register on November 6, 1998 (63 FR 60178). From
the Division of Laboratory Systems, Public Health Practice Program Office,
CDC.
Assisted
Reproductive Technology: Embryo Laboratory
View PDF
435KB
This site links to the (1) January 1999 report entitled Survey of Assisted
Reproductive Technology: Embryo Laboratory Procedures and Practices (119
pages); and (2) Proposed Model Certification Program for Embryo
Laboratories as required by the Fertility Clinic Success Rate and
Certification Act of 1992. From the Division of Laboratory Systems, Public
Health Practice Program Office, CDC.
Pregnancy-related
death associated with heparin and aspirin treatment for infertility, 1996
|
View PDF
268KB
In 1998,
CDC investigated the
death of a pregnant woman who had undergone in-vitro fertilization and aspirin and heparin
therapy. Although researchers could not conclude that the woman's death was caused by the
therapy, the potential for bleeding associated with aspirin and heparin warrants vigorous
scientific investigation and debate before it is recommended for routine use among
in-vitro fertilization patients. Source: MMWR, May 15, 1998 /Vol. 47, No.18.
* |
Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. The CDC is not responsible for the content of the individual organization Web pages found at these links. |
|
|
To learn more about PDF
files and to download PDF files, you need Adobe Acrobat Reader software, which is available free of charge from Adobe.
The HTML version alters the format of the original printed document. Using the PDF version
will preserve the document's formatting and graphics.
|
![Bottom right tab](/peth04/20041029014823im_/http://www.cdc.gov/reproductivehealth/images/02_tab_bot_right.gif)
|
|
|